Catalyst OrthoScience Names Carl O’Connell as President and CEO

January 11, 2022 |

2 min read

Catalyst OrthoScience Inc., a medical device company focused on the upper extremity orthopedics market, has named Carl O’Connell as president and chief executive officer effective immediately.

Jan. 11, 2022 17:00 UTC

NAPLES, Fla.--(BUSINESS WIRE)-- Catalyst OrthoScience Inc. (Catalyst), a medical device company focused on the upper extremity orthopedics market, has named Carl O’Connell as president and chief executive officer effective immediately.

O’Connell replaces Brian Hutchison, who is stepping down. Hutchison joined the company as executive chairman and interim CEO in June 2018 before being asked to stay on as CEO later that same year. He remains a significant investor in the company and will serve as an advisor as needed.

“We are pleased to have Carl step in as president and CEO of Catalyst OrthoScience,” said Carter McNabb, managing director at RC Capital (fka River Cities Capital) and a member of the Catalyst board of directors. “We thank Brian for the work he has done to build this company to where it is today.”

“I am excited to join the Catalyst team and continue the company’s trajectory of significant, sustainable growth,” said O’Connell. “I will be focused on ensuring a smooth transition for our employees, our distributors and our customers over the coming months. I look forward to the commercial launch and expansion of the Archer™ R1 Reverse Shoulder System, as well as continuing to enhance our product portfolio to maintain Catalyst’s leadership position in the marketplace.”

O’Connell brings experience in orthopedics and executive leadership to Catalyst, including leadership positions at Xtant Medical, Wright Medical, Stryker Corporation and most recently at Cerebrotech Medical Systems, a medical device company that develops portable, non-invasive neurotechnology solutions that improve outcomes for stroke patients undergoing neurological assessment.

O’Connell received a bachelor’s degree in psychology and an MBA in business management from Mount Saint Mary’s University.

About Catalyst OrthoScience Inc.

Catalyst OrthoScience is disrupting the usual approaches to shoulder replacement surgery. The Archer™ CSR Total Shoulder System is unique, offering precision and accuracy in shoulder restoration while preserving the patient’s bone and soft tissue. The Archer™ R1 Reverse Shoulder System is a single-tray arthroplasty system that offers surgeon-targeted implant positioning, a streamlined and versatile system, and bone sparing implants. Catalyst OrthoScience’s goal is to develop innovative medical solutions that make orthopedic surgery less invasive and more efficient for both surgeons and patients.

The company has a growing portfolio of patents and pending patents on its distinctive surgical offerings. Headquartered in Naples, Fla., Catalyst products are available across the U.S. For more information, visit www.CatalystOrtho.com.